<i id='9525414D46'><strike id='9525414D46'><tt id='9525414D46'><pre id='9525414D46'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
After affirmative action ruling, medical educators look to 'holistic review' 
Overprescribed: High cost isn't America's only drug problem 
Drug repurposing or repositioning? The language matters 
Brain technologies pose threats that are all too real, experts warn 
How one medical school became remarkably diverse 
Black vets could get higher VA benefits if race not used in lung test 
Wildfire smoke exposes gaps in outdoor worker protections 
Scientific mystery highlights the blind spots in genomics databases 
Medical records are filled with copy 
Medicare Advantage 2025 payments will dip, Biden administration says
How one medical school became remarkably diverse
Medicare Advantage 2025 payments will dip, Biden administration says 
State Dept. review finds Biden bears some blame for Afghanistan failures 
U.K. decision on ALS drug has neurologists, advocates up in arms 
Novavax promises a turnaround & Lilly roils the obesity market 
